OCT1 Polyspecificity—Friend or Foe?
Main Authors: | Marleen J. Meyer, Mladen V. Tzvetkov |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.698153/full |
Similar Items
-
Cloning and Functional Characterization of Dog OCT1 and OCT2: Another Step in Exploring Species Differences in Organic Cation Transporters
by: Marleen Julia Meyer, et al.
Published: (2022-05-01) -
Functional and Pharmacological Comparison of Human, Mouse, and Rat Organic Cation Transporter 1 toward Drug and Pesticide Interaction
by: Saskia Floerl, et al.
Published: (2020-09-01) -
Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes
by: Fizalah Kawoosa, et al.
Published: (2022-05-01) -
Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter
by: Darren eMoss, et al.
Published: (2015-04-01) -
PHARMACOGENETICS OF ORGANIC CATION TRANSPORTERS
by: V. A. Evteev, et al.
Published: (2018-06-01)